Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Which Lead for Q-T Interval Measurements?

      Cardiology

      S. Karger AG

      ECG, Q-T interval measurement, methodology, Lead determination, Q-T interval

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There are several Q-T interval measures (individual lead, mean Q-T interval or Q-T dispersion) from a 12-lead ECG. Which should be used? As the ECG provides twelve different measures of the heart’s ‘true’ Q-T interval, and as, ‘a priori’, no one measure is any better or worse than any other measure at estimating the ‘true’ Q-T interval, the best measure is the average of these twelve measures, i.e., the mean Q-T interval. The best single lead to measure the Q-T interval is the lead that relates most closely to the mean Q-T interval which in 49 subjects with cardiac diseases was lead V<sub>3</sub>, then lead II. The longest lead Q-T interval relates poorly to the mean and to the individual lead Q-T intervals and therefore carried information different to and quite unique from these measures. This unique information is Q-T dispersion which relates well to the longest lead Q-T interval (r = 0.71, p < 0.001).

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: found
          • Article: not found

          QT interval and mortality from coronary artery disease.

           P. Davey (2000)
          Abnormalities in the QT interval can be divided into 3 types, prolongation of the QT interval, increases in the dispersion of the QT interval, and abnormalities in the heart rate dependent behavior of the QT interval. Abnormalities may be found in short or long-term recordings. Prolongation of the QT interval may reflect factors associated with an adverse prognosis in coronary disease and may in itself be arrhythmogenic. The data to date suggest that there is an association between adverse prognosis and QT interval prolongation in coronary disease, both before and after acute myocardial infarctions. This relationship is weak, however, and is not clinically useful. The data as to whether increased QT dispersion postmyocardial infarction relates to adverse prognosis is weak because there is no convincing evidence yet. If there is a relationship it is weak. Abnormalities in the rate dependent behavior of the QT interval are widely found, but as no large scale prospective study with mortality as an endpoint has yet been undertaken the significance of rate dependent abnormalities is uncertain. The widespread introduction of beat-to-beat QT analysis of 24 hour Holter tapes may take QT intervalology into the realm of clinical practice.
            Bookmark

            Author and article information

            Journal
            CRD
            Cardiology
            10.1159/issn.0008-6312
            Cardiology
            S. Karger AG
            0008-6312
            1421-9751
            2000
            February 2001
            02 March 2001
            : 94
            : 3
            : 159-164
            Affiliations
            Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK
            Article
            47311 Cardiology 2000;94:159–164
            10.1159/000047311
            11279321
            © 2001 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            Page count
            Figures: 2, Tables: 4, References: 12, Pages: 6
            Categories
            Arrhythmias, Electrophysiology and Electrocardiography

            Comments

            Comment on this article